SodiUm SeleniTe Adminstration IN Cardiac Surgery (SUSTAIN CSX®-Trial).
Status:
Active, not recruiting
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
The aim of the investigators' research program is to investigate the effects of perioperative
high dose selenium supplementation in high-risk cardiac surgical patients undergoing
complicated open heart surgery. The investigators hypothesize that the therapeutic strategy
tested in this randomized trial may contribute to a fewer complications, less organ injury
and fewer deaths. Before the investigators conducted the large definitive trial, they
conducted a pilot study to assess the feasibility of the protocol, and are rolling the pilot
patients into the definitive trial.
Phase:
Phase 3
Details
Lead Sponsor:
Daren K. Heyland
Collaborators:
biosyn Arzneimittel GmbH Queen's University RWTH Aachen University